Drugs / NYC 0462
last change Apr 2011 re-read 3 minutes ago

NYC 0462

Developed for
psoriasis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT00747032 Comparator Sep 2010 → Feb 2011 psoriasis Fougera Pharmaceuticals Inc. Withdrawn No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NYC 0462 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00747032 ↗
Route Topical “applied to the affected skin” NCT00747032 ↗